T1	Procedure 23 52	ophthalmic surgical procedure
T2	Temporal 53 98	within 6 months of the beginning of the study
T3	Reference_point 93 98	study
R1	Has_temporal Arg1:T1 Arg2:T2	
R2	Has_index Arg1:T2 Arg2:T3	
T4	Condition 130 138	glaucoma
T5	Condition 144 155	abnormality
T6	Qualifier 163 169	cornea
R3	Has_qualifier Arg1:T5 Arg2:T6	
T7	Condition 226 233	allergy
T8	Condition 235 251	hypersensitivity
T9	Drug 264 275	Brimonidine
*	OR T7 T8
T10	Scope 226 251	allergy/ hypersensitivity
R4	AND Arg1:T10 Arg2:T9	
T11	Condition 277 294	Contra-indication
T12	Drug 298 309	Brimonidine
T13	Drug 332 360	monoamine oxidase inhibitors
T14	Drug 362 365	MOA
R5	Subsumes Arg1:T13 Arg2:T14	
R6	AND Arg1:T11 Arg2:T12	
R7	Subsumes Arg1:T11 Arg2:T13	
T15	Informed_consent 368 423	Patients unwilling or unable to provide informed consen
T16	Observation 452 479	difficult airway management
